Hormone therapy may improve cognitive function

A study published inMenopause suggests hormone therapy may improve cognitive function and brain health in menopausal women.MedicalXpress
Source: Society for Endocrinology - Category: Endocrinology Source Type: news

Related Links:

Conclusions: Given that estrogen-alone therapy has been shown to be associated with increased risk of ovarian cancer, these findings are consistent with the hypothesis that adding a progestin each day ameliorates the carcinogenic effects of estrogen on the cells of origin for all histotypes of ovarian cancer.
Source: Epidemiology - Category: Epidemiology Tags: Women’s Health Source Type: research
Objective: Gabapentin is used to treat vasomotor symptoms (VMS) in postmenopausal women with contraindications to hormonal therapy or who prefer alternatives. We investigated the efficacy and tolerability of gabapentin for treating menopausal hot flushes via a meta-analysis. Methods: We searched the PubMed, MEDLINE, EMBASE, and CENTRAL databases for English-language articles published until June, 2018. The following search terms were used: “menopause,” “hot flushes,” “vasomotor symptoms,” “gabapentin,” and “non-hormonal therapy.” Primary outcomes were frequen...
Source: Menopause - Category: OBGYN Tags: Review-Systematic Source Type: research
Impaired sleep is common in menopausal women. The aim was to examine associations between uses of systemic menopausal hormone therapy (MHT) and sleep disturbance in a large population sample.
Source: BMC Women's Health - Category: OBGYN Authors: Tags: Research article Source Type: research
Abstract A variety of structurally and functionally distinct progestins is used in contraception and menopausal hormone therapy (MHT). Some progestins elicit off-target effects by binding to steroid receptors other than the progesterone receptor, which may impact their therapeutic and side-effect profiles. We directly compared the binding affinities, efficacies and potencies of selected progestins via the mineralocorticoid receptor (MR). We did not detect a significant difference in the affinities of medroxyprogesterone acetate (MPA), norethisterone acetate (NET-A), levonorgestrel (LNG), gestodene (GES), etonogest...
Source: Biochemical and Biophysical Research communications - Category: Biochemistry Authors: Tags: Biochem Biophys Res Commun Source Type: research
Abstract Increasing numbers of women experience early menopause due in part to surgical treatment for benign gynecologic disorders and the rise in risk-reducing bilateral salpingo-oophorectomy in women with BRCA mutations. Unfortunately, the adverse health consequences of early loss of ovarian function accelerate the menopausal state and affect multiple systems, including cardiovascular, neurologic, bone, and connective tissue, and affect quality of life owing to vasomotor symptoms, mood, sleep, and sexual function. Yet many clinicians and women remain reluctant to use hormone therapy because of the Women's Health...
Source: Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Obstet Gynecol Source Type: research
Researchers say fear using hormone for hot flashes, mental fogginess and libido problems was a misreading of a landmark 2002 study
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news
Researchers say fear of hormones for hot flashes, mental fogginess and libido problems was a misreading of a landmark 2002 study
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news
No abstract available
Source: Menopause - Category: OBGYN Tags: Editorials Source Type: research
Conclusion: Compared with t-E2, o-CEE appears to slow down the adverse effect of increasing PAT on progression of atherosclerosis. Whether this beneficial association is specific to CEE or to the oral route of CEE administration is unclear and should be assessed further.
Source: Menopause - Category: OBGYN Tags: Original Studies Source Type: research
Conclusions: Long-term HT use and type 2 diabetes interact in their relationship with cataract. This novel finding should be confirmed. If confirmed, women with type 2 diabetes should be informed that long-term HT use increases their risk of cataract. Video Summary:http://links.lww.com/MENO/A519.
Source: Menopause - Category: OBGYN Tags: Original Studies Source Type: research
More News: Brain | Endocrinology | Hormonal Therapy | Hormones | Men | Menopause | Neurology | Study | Women